Low-Dose CT Screening Does Not Damage Chromosomal DNA
|
By MedImaging International staff writers Posted on 01 Apr 2020 |
Lung cancer screening using low-dose chest computed tomography (CT) does not biologically affect human DNA, according to a new study.
Researchers at Hiroshima University (Japan) and Fukushima Medical University (FMU; Japan) conducted a study that compared DNA in 107 patients who underwent low-dose chest CT with that of 102 patients who had standard-dose chest CT; the median effective radiation dose of low-dose CT was 1.5 millisieverts (mSv), while that of the standard CT dose was 5.0 mSv. In addition, blood samples were obtained before and 15 minutes after CT to identify DNA double-strand breaks and chromosome aberrations (CAs) in peripheral blood lymphocytes.
The results revealed that the number of double-strand DNA breaks and CAs increased after the standard dose CT examination, but that the number of double-strand breaks and CAs before and after low dose CT remained the same. The researchers stressed that while the study does not endorse lung cancer screening with low-dose CT, its results could allay concerns over a potential increase in radiation-related cancer risk related to screening programs. The study was published on March 10, 2020, in Radiology.
“We could clearly detect the increase of DNA damage and chromosome aberrations after standard chest CT. In contrast, no significant differences were observed in these biological effects before and after low-dose CT,” said senior author Satoshi Tashiro, MD, PhD, director of the Research Institute for Radiation Biology and Medicine at Hiroshima University. “Even using these sensitive analyses, we could not detect the biological effects of low-dose CT scans. This suggests that application of low-dose CT for lung cancer screening is justified from a biological point of view.”
In Japan, low-dose CT screening has been employed since the 1990s. However, unlike other countries, examinees include light smokers and non-smokers. As a result, a large number of stage one lung cancers are detected, and the survival rate is high.
Related Links:
Hiroshima University
Fukushima Medical University
Researchers at Hiroshima University (Japan) and Fukushima Medical University (FMU; Japan) conducted a study that compared DNA in 107 patients who underwent low-dose chest CT with that of 102 patients who had standard-dose chest CT; the median effective radiation dose of low-dose CT was 1.5 millisieverts (mSv), while that of the standard CT dose was 5.0 mSv. In addition, blood samples were obtained before and 15 minutes after CT to identify DNA double-strand breaks and chromosome aberrations (CAs) in peripheral blood lymphocytes.
The results revealed that the number of double-strand DNA breaks and CAs increased after the standard dose CT examination, but that the number of double-strand breaks and CAs before and after low dose CT remained the same. The researchers stressed that while the study does not endorse lung cancer screening with low-dose CT, its results could allay concerns over a potential increase in radiation-related cancer risk related to screening programs. The study was published on March 10, 2020, in Radiology.
“We could clearly detect the increase of DNA damage and chromosome aberrations after standard chest CT. In contrast, no significant differences were observed in these biological effects before and after low-dose CT,” said senior author Satoshi Tashiro, MD, PhD, director of the Research Institute for Radiation Biology and Medicine at Hiroshima University. “Even using these sensitive analyses, we could not detect the biological effects of low-dose CT scans. This suggests that application of low-dose CT for lung cancer screening is justified from a biological point of view.”
In Japan, low-dose CT screening has been employed since the 1990s. However, unlike other countries, examinees include light smokers and non-smokers. As a result, a large number of stage one lung cancers are detected, and the survival rate is high.
Related Links:
Hiroshima University
Fukushima Medical University
Latest Radiography News
- AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
- Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
- AI Detection Tool Improves Identification of Lobular Breast Cancer
- New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
- AI Boosts Breast Cancer Detection and Cuts Screening Workload
- AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
- Routine Mammograms Could Predict Future Cardiovascular Disease in Women
- AI Detects Early Signs of Aging from Chest X-Rays
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
- New AI Tool Helps Doctors Read Chest X‑Rays Better
Channels
MRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channel
Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
Interventional radiology procedures typically rely on ultrasound, X-ray fluoroscopy, or computed tomography for image guidance. These modalities visualize anatomy but offer limited molecular information,... Read more
AI Model Predicts Radiation Dose Before Prostate Cancer Therapy
Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of disease that progresses despite androgen-deprivation therapy and frequently spreads to bone and visceral organs.... Read moreGeneral/Advanced Imaging
view channel
Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
Obesity surgery improves weight and comorbidity profiles, yet clinicians lack tools to monitor organ-level metabolic recovery after the procedure. A clear view of systemic changes could refine follow-up... Read more
PET Tracer Localizes Overactive Adrenal Glands in Primary Aldosteronism
Primary aldosteronism (Conn’s syndrome) is the leading cause of curable secondary hypertension and results from excess aldosterone produced by the adrenal cortex. Determining whether hormone overproduction... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







